The effect of carbenoxolone sodium on the plasma 11 hydroxycorticoid levels in chronic gastric ulceration.
The mineralcorticoid effects of carbenoxolone sodium are well established and seem related to the ulcer healing of the drug.  In the present study the plasma 11 hydroxycorticoid responses were assessed in 12 patients undergoing treatment with carbenoxolone for chronic gastric ulceration.  After treatment with carbenoxolone for one month the plasma 11 hydroxycoticoid levels rose significantly, suppression by dexamethosone was less marked and the normal diurnal periodicity was abolished.  Carbenoxolone therapy influences the results of tests designed to assess the function of the pituitaryadrenal axis and may lead to sub-clinical adrenocortical hyperfunction.
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D002229:Carbenoxolone / Q000494:pharmacology* / Q000627:therapeutic use; D002908:Chronic Disease; D002940:Circadian Rhythm / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007328:Insulin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D013276:Stomach Ulcer / Q000097:blood* / Q000188:drug therapy; D014315:Triterpenes / Q000494:pharmacology*
D001786:Blood Glucose; D007328:Insulin; D014315:Triterpenes; D003907:Dexamethasone; D013006:Growth Hormone; D002229:Carbenoxolone; D006854:Hydrocortisone